Celltrion Wins Race For High-Concentration Adalimumab

Receives Positive CHMP Opinion For 100mg/ml Biosimilar To Humira

 
• By David Wallace
  
Man Winning Race
Celltrion expects to receive the first approval for a high-concentration adalimumab biosimilar • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin